Mast cell homeostasis and the JAK-STAT pathway

被引:77
|
作者
Morales, J. K.
Falanga, Y. T.
Depcrynski, A.
Fernando, J.
Ryan, J. J. [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA
基金
美国国家卫生研究院;
关键词
mast cell; JAK; STAT; allergy; IgE; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; AIRWAY SMOOTH-MUSCLE; PROTOONCOGENE C-KIT; SERINE PHOSPHORYLATION; DNA-BINDING; SIGNAL-TRANSDUCTION; SYSTEMIC MASTOCYTOSIS; DASATINIB BMS-354825; NEGATIVE REGULATION;
D O I
10.1038/gene.2010.35
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Janus kinase/signal transducer and activator of transcription (JAK-STAT) pathway mediates important responses in immune cells. Activation of any of the four JAK family members leads to phosphorylation of one or more of seven STAT family members. Phosphorylation of STAT family members leads to their dimerization and translocation into the nucleus, in which they bind specific DNA sequences to activate gene transcription. Regulation of JAKs and STATs therefore has a significant effect on signal transduction and subsequent cellular responses. Mast cells are important mediators of allergic disease and asthma. These cells have the ability to cause profound inflammation and vasodilation upon the release of preformed mediators, as well as subsequent synthesis of new inflammatory mediators. The regulation of mast cells is therefore of intense interest for the treatment of allergic disease. An important regulator of mast cells, STAT5, is activated downstream of the receptors for immunoglobulin E, interleukin-3 and stem cell factor. STAT5 contributes to mast cell homeostasis, by mediating proliferation, survival, and mediator release. Regulators of the JAK-STAT pathway, such as the suppressors of cytokine signaling (SOCS) and protein inhibitor of activated STAT (PIAS) proteins, are required to fine tune the immune response and maintain homeostasis. A better understanding of the role and regulation of JAKs and STATs in mast cells is vital for the development of new therapeutics. Genes and Immunity (2010) 11, 599-608; doi: 10.1038/gene.2010.35; published online 10 June 2010
引用
收藏
页码:599 / 608
页数:10
相关论文
共 50 条
  • [1] Mast cell homeostasis and the JAK–STAT pathway
    J K Morales
    Y T Falanga
    A Depcrynski
    J Fernando
    J J Ryan
    [J]. Genes & Immunity, 2010, 11 : 599 - 608
  • [2] The Jak-STAT pathway
    Imada, K
    Leonard, WJ
    [J]. MOLECULAR IMMUNOLOGY, 2000, 37 (1-2) : 1 - 11
  • [3] The JAK-STAT Pathway at Twenty
    Stark, George R.
    Darnell, James E., Jr.
    [J]. IMMUNITY, 2012, 36 (04) : 503 - 514
  • [4] The JAK-STAT pathway in Drosophila
    Hou, XS
    Perrimon, N
    [J]. TRENDS IN GENETICS, 1997, 13 (03) : 105 - 110
  • [5] Baseline JAK-STAT signaling maintains immune cell homeostasis
    Bock, Christoph
    Decker, Thomas
    Mueller, Mathias
    [J]. NATURE IMMUNOLOGY, 2024, 25 (05) : 741 - 742
  • [6] In vivo dissection of the JAK-STAT pathway
    Coulombel, L
    Dumenil, D
    [J]. M S-MEDECINE SCIENCES, 1998, 14 (10): : 1129 - 1131
  • [7] Arsenic inhibition of the JAK-STAT pathway
    Haiyun Y Cheng
    Ping Li
    Michael David
    Thomas E Smithgall
    Lili Feng
    Michael W Lieberman
    [J]. Oncogene, 2004, 23 : 3603 - 3612
  • [8] JAK-STAT pathway inhibitors in dermatology
    Miot, Helio Amante
    Criado, Paulo Ricardo
    de Castro, Caio Cesar Silva
    Ianhez, Mayra
    Talhari, Carolina
    Ramos, Paulo Mueller
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (05) : 656 - 677
  • [9] Arsenic inhibition of the JAK-STAT pathway
    Cheng, HYY
    Li, P
    David, M
    Smithgall, TE
    Feng, LL
    Lieberman, MW
    [J]. ONCOGENE, 2004, 23 (20) : 3603 - 3612
  • [10] JAK-STAT pathway activation in COPD
    Yew-Booth, Liang
    Birrell, Mark A.
    Lau, Ming Sum
    Baker, Katie
    Jones, Victoria
    Kilty, Iain
    Belvisi, Maria G.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (03) : 843 - 845